Serum level of CXCL 12 in patients with systemic lupus erythematosus: Is it worthy for predilection of lupus nephritis?

Kyttaris, 2005, New insight into the pathogenesis of systemic lupus, Curr Rheumatol Rep, 7, 469, 10.1007/s11926-005-0054-3 Fairhurst, 2006, Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease, Adv Immunol, 92, 1, 10.1016/S0065-2776(06)92001-X Lech, 2013, The Pathogenesis of lupus nephritis, J Am Soc Nephrol, 9, 1357, 10.1681/ASN.2013010026 Liu, 2014, Lupus nephritis: from pathogenesis to targets for biologic treatment, Nephron Clin Pract, 3–4, 224, 10.1159/000368581 Espeli, 2011, Local renal autoantibody production in lupus nephritis, J Am Soc Nephrol, 2, 296, 10.1681/ASN.2010050515 Gheita, 2015, Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage, Acta Reumatol Port, 40, 145 Aringer, 2020, Inflammatory markers in systemic lupus erythematosus, J Autoimmun., 110, 10.1016/j.jaut.2019.102374 Baggiolini, 1994, Interleukin and chemotactic cytokines – CXC and CC chemokines, Adv Immunol, 55, 97, 10.1016/S0065-2776(08)60509-X Muhsin, 2020, Predictive significance of CXCL8, CXCL10 and CXCL16 in juvenile idiopathic and rheumatoid arthritis Iraqi patients, Egyptian Rheumatol, 42, 153, 10.1016/j.ejr.2019.06.002 Allam, 2019, Clinical significance of serum B cell chemokine (CXCL13) in early rheumatoid arthritis patients, Egypt Rheumatol, 41, 11, 10.1016/j.ejr.2018.04.003 El-Sergany, 2011, Increased expression of soluble fractalkine (CX3CL1) in systemic sclerosis – possible role in vascular inflammation, Egyptian Rheumatol, 33, 93, 10.1016/j.ejr.2011.03.004 Burger, 2006, CXCR4 a key receptor in the crosstalk between tumor cells and their microenvironment, Blood, 107, 1761, 10.1182/blood-2005-08-3182 Juarez, 2004, Chemokines and their receptors as therapeutic targets: the role of SDF-1/CXCR4 axis, Curr Pharm Des, 10, 1245, 10.2174/1381612043452640 Balabanian, 2003, Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis inmurine lupus, J Immunol, 170, 3392, 10.4049/jimmunol.170.6.3392 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, 64, 2677, 10.1002/art.34473 Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum, 35, 630, 10.1002/art.1780350606 Gladman, 1996, The development and initial validation of the SLICC/ACR damage index for SLE, Arthritis Rheum, 39, 363, 10.1002/art.1780390303 Weening, 2004, The classification of glomerulonephritis in systemic lupus erythematosus revisited, J Am Soc Nephrol, 2, 241, 10.1097/01.ASN.0000108969.21691.5D Fathollahi, 2018, Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder, Lupus, 27, 1053, 10.1177/0961203318768889 Tsokos, 2016, New insights into the immunopathogenesis of systemic lupus erythematosus, Nat Rev Rheumatol, 12, 716, 10.1038/nrrheum.2016.186 Badr, 2015, Infection of female BWF1 lupus mice with malaria parasite attenuates B cell autoreactivity by modulating the CXCL12/CXCR4 axis and its downstream signals PI3K/AKT, NFκB and ERK, PLoS One, 10, 125, 10.1371/journal.pone.0125340 Hanaoka, 2015, Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus, Clin Exp Rheumatol, 6, 863 Wang, 2010, Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus, Arthritis Rheum, 11, 3436, 10.1002/art.27685 Biajoux, 2012, Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus, J Transl Med, 10, 251, 10.1186/1479-5876-10-251 Hrycek, 2013, Serum levels of selected chemokines in systemic lupus erythematosus patients, Rheumatol Int, 9, 2423, 10.1007/s00296-012-2393-5 Klarquist, 2016, Dendritic cells in systemic lupus erythematosus: from pathogenic players to therapeutic tools, Mediat Inflamm, 2016, 5045248, 10.1155/2016/5045248 Wang, 2009, CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus, J Immunol, 182, 4448, 10.4049/jimmunol.0801920 Bing, 2016, Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR-9 pathway, J Cell Mol Med, 20, 949, 10.1111/jcmm.12795 Zainodini, 2013, Differential Expression of CXCL1, CXCL9 CXCL10 and CXCL12 Chemokines in Alopecia Areata, Iran J Immunol, 10, 40 Karin, 2010, The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease, J Leukoc Biol, 88, 463, 10.1189/jlb.0909602 Guilpain, 2011, The expression of CXCR4/CXCL12 determines subsets of patients in systemic lupus erythematosus, Bio Med Central, 9, 60 Yousry, 2015, SDF-1(CXCL12) polymorphisms in Egyptian patients with systemic lupus erythematosus (SLE): a pilot study, Comp Clin Pathol, 6, 1535, 10.1007/s00580-015-2112-1 El Desouky, 2015, Correlation between various clinical parameters of systemic lupus erythematosus and levels of anti-histone and anti-chromatin antibodies, Egyptian Rheumatol, 3, 97, 10.1016/j.ejr.2014.11.005 Su, 2014, The association between autoantibodies and peripheral neuropathy in lupus nephritis, Biomed Res Int, 2014, 10.1155/2014/524940 Battinelli, 2011, Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis, Blood, 118, 1359, 10.1182/blood-2011-02-334524 Lai, 2008, Upregulation of stromal cell-derived factor 1 (SDF-1) expression in microvasculature endothelial cells in retinal ischemia-reperfusion injury, Graefes Arch Clin Exp Ophthalmol, 246, 1707, 10.1007/s00417-008-0907-3 Stokman, 2010, SDF-1 provides morphological and functional protection against renal ischaemia/reperfusion injury, Nephrol Dial Transplant, 25, 3852, 10.1093/ndt/gfq311 Liao, 2016, Chemokines and chemokine receptors in the development of lupus nephritis, Mediat Inflamm, 10, 11 Goletti, 2018, MMP7 and CXCL12: two promising biomarkers in lupus nephritis, Arthritis Rheumatol, 70, 10 Rizzo, 2013, Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat, Am J Pathol, 6, 1769, 10.1016/j.ajpath.2013.08.008